Literature DB >> 2153394

Procoagulant activity of human tumours: existence of Xa and thrombin-like activities.

R Sarode1, N Marwaha, N M Gupta.   

Abstract

We have analysed 15 infiltrating duct carcinomas of the breast, 10 gastrointestinal adenocarcinomas, one each of the thyroid and larynx, and four mesenchymal tumours for the presence and the nature of procoagulant activity (PCA). The metastatic tumours had a significantly higher PCA (P = 0.01-0.001) as compared to the non-metastatic tumours in the respective groups, and almost 20-25 times the activity as compared to normal tissue (P = 0.001). Although the majority of the tumours had FVII-dependent tissue thromboplastin-like activity, some of the tumour homogenates revealed the presence of an FVII-independent PCA. Unlike the known alternate PCA, which acts via factor X activation, this PCA was factor X independent. It caused clot formation in FX-deficient plasma (six cases) and purified fibrinogen solution (four cases), indicating the presence of a Xa-like enzyme or a thrombin-like activity respectively.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2153394      PMCID: PMC1971320          DOI: 10.1038/bjc.1990.7

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  8 in total

1.  Coagulative properties of cancers.

Authors:  R A O'MEARA
Journal:  Ir J Med Sci       Date:  1958-10       Impact factor: 1.568

2.  Plasminogen activators, plasminogen activator inhibitors and procoagulant analyzed in twenty human tumor cell lines.

Authors:  J F Cajot; E K Kruithof; W D Schleuning; B Sordat; F Bachmann
Journal:  Int J Cancer       Date:  1986-11-15       Impact factor: 7.396

3.  Activation of blood coagulation in cancer: Trousseau's syndrome revisited.

Authors:  F R Rickles; R L Edwards
Journal:  Blood       Date:  1983-07       Impact factor: 22.113

4.  The role of hemostasis and fibrinolysis in the metastatic spread of cancer.

Authors:  G Markus
Journal:  Semin Thromb Hemost       Date:  1984-01       Impact factor: 4.180

5.  A factor X-activating cysteine protease from malignant tissue.

Authors:  S G Gordon; B A Cross
Journal:  J Clin Invest       Date:  1981-06       Impact factor: 14.808

6.  Alterations of hemostasis associated with malignancy: etiology, pathophysiology, diagnosis and management.

Authors:  R L Bick
Journal:  Semin Thromb Hemost       Date:  1978       Impact factor: 4.180

7.  Factor X-activating activity from Lewis lung carcinoma.

Authors:  P Hilgard; P Whur
Journal:  Br J Cancer       Date:  1980-04       Impact factor: 7.640

8.  Evidence that cells from experimental tumours can activate coagulation factor X.

Authors:  L Curatolo; M Colucci; A L Cambini; A Poggi; L Morasca; M B Donati; N Semeraro
Journal:  Br J Cancer       Date:  1979-08       Impact factor: 7.640

  8 in total
  2 in total

Review 1.  General surgery.

Authors:  I Taylor
Journal:  Postgrad Med J       Date:  1991-10       Impact factor: 2.401

Review 2.  Thrombosis in Thyroid Cancer.

Authors:  Arash Ordookhani; Abbas Motazedi; Kenneth D Burman
Journal:  Int J Endocrinol Metab       Date:  2017-10-31
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.